• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.影响十一酸睾酮油注射液肌肉注射后疼痛时间进程的因素。
Asian J Androl. 2010 Mar;12(2):227-33. doi: 10.1038/aja.2010.1. Epub 2010 Feb 1.
2
Tolerability of intramuscular injections of testosterone ester in oil vehicle.油性载体中睾酮酯肌肉注射的耐受性。
Hum Reprod. 1995 Apr;10(4):862-5. doi: 10.1093/oxfordjournals.humrep.a136051.
3
Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.十一酸睾酮皮下注射的药代动力学及可接受性
J Endocr Soc. 2019 Jun 28;3(8):1531-1540. doi: 10.1210/js.2019-00134. eCollection 2019 Aug 1.
4
Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.十一酸睾酮肌内注射治疗男性性腺功能减退:I期研究
Eur J Endocrinol. 1999 May;140(5):414-9. doi: 10.1530/eje.0.1400414.
5
A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.十一酸睾酮注射液在性腺功能减退男性中的药代动力学研究。
J Androl. 1998 Nov-Dec;19(6):761-8.
6
Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism.新型十一酸睾酮长效制剂与庚酸睾酮用于男性性腺功能减退肌内雄激素治疗的比较。
J Endocrinol Invest. 2008 Aug;31(8):718-23. doi: 10.1007/BF03346421.
7
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.在性腺功能减退男性中,重复肌肉注射十一酸睾酮进行替代治疗。
Clin Endocrinol (Oxf). 1999 Dec;51(6):757-63. doi: 10.1046/j.1365-2265.1999.00881.x.
8
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.雄激素受体基因CAG重复序列长度和体重指数调节性腺功能减退男性长期肌内注射十一酸睾酮治疗的安全性。
J Clin Endocrinol Metab. 2007 Oct;92(10):3844-53. doi: 10.1210/jc.2007-0620. Epub 2007 Jul 17.
9
Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial.长效十一酸睾酮注射液在性腺功能减退男性中的药代动力学与安全性:一项为期84周的III期临床试验。
J Androl. 2010 Sep-Oct;31(5):457-65. doi: 10.2164/jandrol.109.009597. Epub 2010 Feb 4.
10
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.IPASS:一项针对全球 1438 名男性性腺功能减退症患者使用注射用十一酸睾酮治疗的耐受性和有效性的研究。
J Sex Med. 2013 Feb;10(2):579-88. doi: 10.1111/j.1743-6109.2012.02853.x. Epub 2012 Jul 19.

引用本文的文献

1
The world's first anabolic-androgenic steroid testing trial: A two-phase pilot combining chemical analysis, results dissemination and community feedback.世界首个合成代谢雄激素类固醇检测试验:一项结合化学分析、结果传播及社区反馈的两阶段试点项目。
Addiction. 2025 Jul;120(7):1366-1377. doi: 10.1111/add.70009. Epub 2025 Feb 6.
2
Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges.可生物降解长效注射剂:平台技术与产业挑战
Handb Exp Pharmacol. 2024;284:133-150. doi: 10.1007/164_2023_651.
3
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India.印度男性性腺功能减退症诊断与管理专家意见
Int J Endocrinol. 2023 Feb 22;2023:4408697. doi: 10.1155/2023/4408697. eCollection 2023.
4
Occurrence of pulmonary oil microembolism (POME) with intramuscular testosterone undecanoate injection: literature review.肌肉注射十一酸睾酮致肺油微栓塞(POME)的发生:文献复习。
Int J Impot Res. 2023 Aug;35(5):439-446. doi: 10.1038/s41443-022-00585-1. Epub 2022 May 24.
5
Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option.皮下注射睾酮治疗:一种安全、实用且合理的选择。
J Clin Endocrinol Metab. 2022 Feb 17;107(3):614-626. doi: 10.1210/clinem/dgab772.
6
Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men.十一酸睾酮治疗性腺功能减退男性和跨性别男性的最佳注射间隔
Endocr Connect. 2021 Jul 14;10(7):758-766. doi: 10.1530/EC-21-0109.
7
Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art.纳米技术作为可注射肠胃外制剂开发的平台:技术诀窍与最新进展综述
Pharmaceutics. 2020 Jun 3;12(6):510. doi: 10.3390/pharmaceutics12060510.
8
Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis.十一酸睾酮注射后发生肺油微栓塞:上市后安全性分析。
Sex Med. 2020 Jun;8(2):237-242. doi: 10.1016/j.esxm.2020.01.009. Epub 2020 Mar 14.
9
Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model.皮下给予头孢曲松钠在动物模型中的局部组织反应。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.02090-19.
10
Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.十一酸睾酮皮下注射的药代动力学及可接受性
J Endocr Soc. 2019 Jun 28;3(8):1531-1540. doi: 10.1210/js.2019-00134. eCollection 2019 Aug 1.

本文引用的文献

1
Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals.长效十一酸睾酮肌肉注射36个月用于治疗女性变男性跨性别者的安全性方面
Eur J Endocrinol. 2009 Nov;161(5):795-8. doi: 10.1530/EJE-09-0412. Epub 2009 Sep 11.
2
Pain and aging: the emergence of a new subfield of pain research.疼痛与衰老:疼痛研究新子领域的兴起
J Pain. 2009 Apr;10(4):343-53. doi: 10.1016/j.jpain.2008.10.013.
3
Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men.十一酸睾酮注射液在中国男性中的多中心避孕效果试验。
J Clin Endocrinol Metab. 2009 Jun;94(6):1910-5. doi: 10.1210/jc.2008-1846. Epub 2009 Mar 17.
4
Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men.长效十一酸睾酮制剂与庚酸睾酮对性腺功能减退男性性功能和情绪影响的比较
Eur J Endocrinol. 2009 May;160(5):815-9. doi: 10.1530/EJE-08-0830. Epub 2009 Feb 18.
5
On the origin of sensory impairment and altered pain perception in Prader-Willi syndrome: a neurophysiological study.普拉德-威利综合征中感觉障碍及疼痛感知改变的起源:一项神经生理学研究
Eur J Pain. 2009 Sep;13(8):829-35. doi: 10.1016/j.ejpain.2008.09.011. Epub 2008 Nov 4.
6
Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.十一酸睾酮单独使用或与来曲唑或度他雄胺联合使用对女变男跨性别者的影响。
J Sex Med. 2008 Oct;5(10):2442-53. doi: 10.1111/j.1743-6109.2008.00909.x. Epub 2008 Jul 1.
7
Male hormonal contraception: a double-blind, placebo-controlled study.男性激素避孕:一项双盲、安慰剂对照研究。
J Clin Endocrinol Metab. 2008 Jul;93(7):2572-80. doi: 10.1210/jc.2008-0265. Epub 2008 Apr 15.
8
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.雄激素受体基因CAG重复序列长度和体重指数调节性腺功能减退男性长期肌内注射十一酸睾酮治疗的安全性。
J Clin Endocrinol Metab. 2007 Oct;92(10):3844-53. doi: 10.1210/jc.2007-0620. Epub 2007 Jul 17.
9
Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections.基于臀肌肌内注射失败的计算机断层扫描测量臀肌皮下脂肪厚度
Can Assoc Radiol J. 2007 Apr;58(2):72-5.
10
More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.在新型长效注射用十一酸睾酮方面拥有超过八年的实践经验。
Asian J Androl. 2007 May;9(3):291-7. doi: 10.1111/j.1745-7262.2007.00275.x.

影响十一酸睾酮油注射液肌肉注射后疼痛时间进程的因素。

Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.

机构信息

Andrology Department, Concord Hospital & ANZAC Research Institute, Sydney, NSW, Australia.

出版信息

Asian J Androl. 2010 Mar;12(2):227-33. doi: 10.1038/aja.2010.1. Epub 2010 Feb 1.

DOI:10.1038/aja.2010.1
PMID:20118950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3739103/
Abstract

Pain following depot intramuscular (IM) injection of oil vehicle-based drugs has been little studied. This study aimed to determine prospectively the prevalence, determinants, severity and functional consequences of pain during the week after IM injection of 1 000 mg testosterone undecanoate (TU) in a 4-mL castor oil vehicle. Androgen-deficient men receiving regular T replacement therapy at an academic andrology clinic were recruited to report pain scores using a coloured visual linear analogue scale at seven times over the first day and daily for a week after a deep IM gluteal injection. The time course and covariables influencing pain scores were analysed by mixed model analysis of variance (ANOVA). Following 168 injections in 125 men, pain was reported by 80% of men, peaking immediately after injection, reaching only moderate severity, lasting 1-2 days and returning to baseline by day 4. The pain required little analgesic use and produced minimal interference in daily activities. The time course of pain scores was reproducible in the 43 men who underwent two consecutive injections. Pain was more severe in men who had an earlier painful injection, but less severe in older and more obese men. There were negligible differences in post-injection pain experience between experienced nurses administering injections. Deep IM gluteal injection of depot TU in 4-mL castor oil is well tolerated and post-injection pain is influenced by earlier painful injection experience, as well as age and obesity.

摘要

肌肉内(IM)注射油基药物后出现疼痛的问题研究较少。本研究旨在前瞻性确定 1000mg 十一酸睾酮(TU)以 4ml 蓖麻油为载体深部肌内注射后一周内疼痛的发生率、决定因素、严重程度和对功能的影响。在学术男科诊所接受常规睾酮替代治疗的雄激素缺乏男性,在深部臀部 IM 注射后第一天的 7 次和每天一次使用彩色视觉线性模拟量表报告疼痛评分。采用混合模型方差分析(ANOVA)分析疼痛评分的时间过程和协变量。在 125 名男性中进行了 168 次注射后,80%的男性报告出现疼痛,疼痛在注射后立即达到高峰,程度仅为中度,持续 1-2 天,第 4 天恢复基线。疼痛需要很少的镇痛药治疗,对日常活动的干扰极小。43 名连续接受两次注射的男性的疼痛评分时间过程具有可重复性。先前有过疼痛注射经历的男性疼痛更严重,但年龄较大和肥胖的男性疼痛程度较轻。经验丰富的护士进行注射时,注射后疼痛体验差异可以忽略不计。以 4ml 蓖麻油为载体深部肌内注射 TU 耐受性良好,注射后疼痛受先前疼痛注射经历以及年龄和肥胖的影响。